Continuing perioperative estrogen therapy does not increase venous thromboembolic events in transgender patients: a systematic review and meta-analysis. — J Badreddine (2022) | RDL Network
Continuing perioperative estrogen therapy does not increase venous thromboembolic events in transgender patients: a systematic review and meta-analysis.
Article 2022 en
Authors
JB
J Badreddine
ML
Moonhyung Lee
KM
K Mishra
Abstract
1 min read
Perioperative estrogen therapy does not increase VTE risk on male to female gender-affirming surgery. Therefore, estrogen therapy may be continued perioperatively in vaginoplasty. More prospective studies are needed.
Nicole M. Kuderer, Marek S. Poniewierski, Eva Culakova, Gary H. Lyman, Alok A. Khorana, Ingrid Pabinger, Giancarlo Agnelli, Howard A. Liebman, Éric Vicaut, Guy Meyer, Frances A. Shepherd
Ayelet Shapira‐Daniels, Dana King, Sari L. Reisner, Lauren B. Beach, Oseiwe Eromosele, Sandhiya Ravichandran, Robert Helm, Emelia Benjamin, Carl G. Streed
Bilal H. Kirmani, Siôn Jones, Andrew D Muir, Graham S. Hillis, Ralph Stewart, Cheng‐Hon Yap, Rebecca Maier, Helen Hancock, James Wason, Benoy N. Shah, Richard Whitlock, Professor Gregory Lip, Enoch Akowuah
Discussion(0)
No comments yet. Be the first to comment.